Room 217 D

Drug Delivery 2

The fields of biomaterials and controlled drug release are highly intertwined, with the advances in one field concomitantly advancing the other. In many cases, the work developed is of broader interest that does not easily fit into more specialized themed sessions. In this session, leading research in the area of drug delivery as it relates to biomaterials will be presented.

Drug Delivery

The fields of biomaterials and controlled drug release are highly intertwined, with the advances in one field concomitantly advancing the other. In many cases, the work developed is of broader interest that does not easily fit into more specialized themed sessions. In this session, leading research in the area of drug delivery as it relates to biomaterials will be presented.

Recent Advances in Surface Modication of Biomaterials 2

A variety of technologies including but not limited to grafting, plasma treatment, silanization, self-assembled monolayers, layer-by-layer multilayer polyelectrolytes, physical and chemical vapor deposition methods, ion beam implantation, PEGylation, and surface modifying additives are commonly used to modify the surface of biomaterials. This general session will cover the recent advances in these technologies.

Modulating the Neural Microenvironment

Tissue engineering / regenerative medicine approaches are uniquely positioned to address neural injury/disease pathologies. Specifically, the cellular microenvironment plays a critical role in directing the fate of the therapeutic interventions. This session will focus on biomaterial-based strategies to engineer and modulate neural microenvironment. Abstracts will span from fundamental studies that elucidate critical instructive cues found within the injury or disease neural microenvironment to developing regenerative therapeutics aimed at modulating the neural microenvironment.

Biomimetic Materials for Tissue Engineering

Recently, biomaterial scientists have added bioactivity to their design toolbox in the development of new materials. These advanced biomaterials add another dimension of guided interaction with the body by mimicking the native remodeling processes, e.g. biological recognition, adhesion sites, substrate-dictated differentiation, or cell-guided enzymatic degradation. This session will review current state of the art in the development of biomimetic materials and the fundamental studies that use these materials to identify key substrate characteristics that support desired cell behavior.

Drug Delivery for Immunomodulation

Controlled drug delivery to activate or suppress immune cells is of strong interest in a broad range of therapeutic applications. This session focuses on new approaches in drug delivery to selectively target immune cells in peripheral tissues and at the primary sites of immunological reactions. Studies regarding the physio-chemical factors that influence drug transport into the lymphoid tissues are also appropriate for this session. Finally, biomaterials delivering anti-inflammatory molecules or other immune modulatory factors are also appropriate for this session.

Recent Advances in Surface Modificaion of Biomaterials

A variety of technologies including but not limited to grafting, plasma treatment, silanization, self-assembled monolayers, layer-by-layer multilayer polyelectrolytes, physical and chemical vapor deposition methods, ion beam implantation, PEGylation, and surface modifying additives are commonly used to modify the surface of biomaterials. This general session will cover the recent advances in these technologies.

SFB Annual Business Meeting

The Society For Biomaterials Annual Business Meeting will inlucde breif remarks from the C. Willaim Hall and SFB Award for Service recipients, as well as an overview of the Society's financial standing, a vote on a new Bylaws Amendment, and the election of memebrs to the Awards, Ceremonies, and Nominations Committee.